Wednesday, October 14, 2015
8:00 a.m. - 5:00 p.m.


Renaissance Hotel
999 Ninth St. NW
Washington, D.C. 20001


Due to a city-wide event, rooms in DC are in high demand, and we encourage you to make hotel reservations as soon as possible.

PMC/BIO's block of hotel rooms at the Renaissance is now full. To inquire about regular rooms that may still be available, you may contact the hotel at 202-898-9000.

In addition to the Renaissance, we suggest the following nearby hotels:

Marriott Marquis (.1 miles)
901 Massachusetts Ave, NW

Hotel Monaco (.4 miles)
700 F Street NW

Cambria Suites (.5 miles)
899 O Street, NW

The Donovan (.5 miles)
155 14th Street NW

Embassy Suites Convention Center (.2 miles)
900 10th Street NW

Hampton Inn Convention Center (.3 miles)
901 6th Street NW


Sponsorship opportunities for this event are available. For more information, contact Mary Bordoni at mbordoni@personalizedmedicinecoalition.org.


David Davenport
Office Administrator
Personalized Medicine Coalition

The 2nd PMC/BIO Solutions Summit

The Personalized Medicine Coalition (PMC) and the Biotechnology Industry Organization (BIO) are convening a national summit, Integrating Personalized Medicine into Health Care, on October 14, 2015 at the Renaissance Downtown Hotel in Washington, D.C. to examine the integration of personalized medicine into the health care system. The summit will focus on issues related to the adoption of personalized medicine beyond the challenges of regulation and reimbursement.

At the summit, we will discuss solutions that address barriers facing personalized medicine, including:

  • The relationship between published evidence, clinical guidelines and the actual utilization of personalized medicine products in the clinic
  • The efficiency of utilization of personalized medicine products throughout the health care ecosystem
  • The widespread and adequate education regarding the use of personalized medicine products among providers, patients and payers

Who Should Attend?

Representatives from self-insured employers, pharmacy benefit managers, investors, personalized medicine diagnostic developers and manufacturers, federal policymakers and representatives from patient organizations, provider specialty societies and clinical research organizations.